The significant keywords include factor-v-Leiden, inherited thrombophilia, activated protein-c, low-dose aspirin, molecular-weigh heparin, polymorphism, etc. All the keywords indicated that research about thrombophilia and RPL focused on its etiology, diagnostics, and therapeutics. The gene discussed is F5; the disease is thrombophilia.